170 related articles for article (PubMed ID: 20120841)
1. Adjuvant treatment after orthotopic liver transplantation: is it really necessary?
Kim R; Tan A; Estfan B; Aucejo F
Oncology (Williston Park); 2009 Dec; 23(14):1276-81. PubMed ID: 20120841
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant treatment of hepatocellular carcinoma after orthotopic liver transplantation: do we really need this?
Fujiki M; Aucejo F; Kim R
Clin Transplant; 2013; 27(2):169-77. PubMed ID: 23216662
[TBL] [Abstract][Full Text] [Related]
3. Getting a handle on posttransplant recurrence of HCC.
de Vera ME
Oncology (Williston Park); 2009 Dec; 23(14):1287, 1291. PubMed ID: 20120842
[No Abstract] [Full Text] [Related]
4. Predictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis C.
Shimoda M; Ghobrial RM; Carmody IC; Anselmo DM; Farmer DG; Yersiz H; Chen P; Dawson S; Durazo F; Han S; Goldstein LI; Saab S; Hiatt J; Busuttil RW
Liver Transpl; 2004 Dec; 10(12):1478-86. PubMed ID: 15558585
[TBL] [Abstract][Full Text] [Related]
5. [Adjuvant chemotherapy after orthotopic liver transplantation for advanced hepatocellular carcinoma].
Zhang ZH; Ma LW; Song SB; Xiu DR; Wang JJ; Yang XX; Jia YM
Zhonghua Zhong Liu Za Zhi; 2005 Jan; 27(1):45-7. PubMed ID: 15771799
[TBL] [Abstract][Full Text] [Related]
6. [Clinical study of adjuvant individualized chemotherapy for hepatocellular carcinoma after liver transplantation].
Chen GH; Lu MQ; Cai CJ; Yang Y; He XS; Zhu XF
Zhonghua Wai Ke Za Zhi; 2004 Sep; 42(17):1040-3. PubMed ID: 15498315
[TBL] [Abstract][Full Text] [Related]
7. Hepatocellular carcinoma downstaging in liver transplantation.
Yu CY; Ou HY; Huang TL; Chen TY; Tsang LL; Chen CL; Cheng YF
Transplant Proc; 2012 Mar; 44(2):412-4. PubMed ID: 22410030
[TBL] [Abstract][Full Text] [Related]
8. Surgical treatment of hepatocellular carcinoma beyond Milan criteria. Results of liver resection, salvage transplantation, and primary liver transplantation.
Facciuto ME; Koneru B; Rocca JP; Wolf DC; Kim-Schluger L; Visintainer P; Klein KM; Chun H; Marvin M; Rozenblit G; Rodriguez-Davalos M; Sheiner PA
Ann Surg Oncol; 2008 May; 15(5):1383-91. PubMed ID: 18320284
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of locoregional therapy before living donor liver transplantation in patients with hepatocellular carcinoma who meet the Milan criteria.
Kim JM; Kwon CH; Joh JW; Choi MS; Lee JH; Koh KC; Paik SW; Kim GS; Kim SJ; Lee SK; Yoo BC
Transplant Proc; 2012 Mar; 44(2):403-8. PubMed ID: 22410028
[TBL] [Abstract][Full Text] [Related]
10. Recurrence of hepatocellular carcinoma following liver transplantation: a review of preoperative and postoperative prognostic indicators.
Zimmerman MA; Ghobrial RM; Tong MJ; Hiatt JR; Cameron AM; Hong J; Busuttil RW
Arch Surg; 2008 Feb; 143(2):182-8; discussion 188. PubMed ID: 18283144
[TBL] [Abstract][Full Text] [Related]
11. Non-resective ablation therapy for hepatocellular carcinoma: effectiveness measured by intention-to-treat and dropout from liver transplant waiting list.
Fisher RA; Maluf D; Cotterell AH; Stravitz T; Wolfe L; Luketic V; Sterling R; Shiffman M; Posner M
Clin Transplant; 2004 Oct; 18(5):502-12. PubMed ID: 15344951
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant chemotherapy improves survival after liver transplantation for hepatocellular carcinoma.
Olthoff KM; Rosove MH; Shackleton CR; Imagawa DK; Farmer DG; Northcross P; Pakrasi AL; Martin P; Goldstein LI; Shaked A
Ann Surg; 1995 Jun; 221(6):734-41; discussion 731-43. PubMed ID: 7794077
[TBL] [Abstract][Full Text] [Related]
13. Strategies for the management of hepatocellular carcinoma.
Schwartz M; Roayaie S; Konstadoulakis M
Nat Clin Pract Oncol; 2007 Jul; 4(7):424-32. PubMed ID: 17597707
[TBL] [Abstract][Full Text] [Related]
14. [Liver transplantation for hepatocellular carcinoma: a report of 60 cases].
Chen GH; Yang Y; Lu MQ; Cai CJ; He XS; Zhu XF; Xu C; Li H; Huang JF
Zhonghua Wai Ke Za Zhi; 2004 Apr; 42(7):413-6. PubMed ID: 15144669
[TBL] [Abstract][Full Text] [Related]
15. [The value of portal vein chemotherapy after radical resection in delaying intrahepatic recurrence of stage II primary hepatocellular carcinoma].
Zhang GQ; Ge L; Ding W; Li HJ
Ai Zheng; 2008 Dec; 27(12):1297-301. PubMed ID: 19079997
[TBL] [Abstract][Full Text] [Related]
16. Uracil-tegafur as an adjuvant for hepatocellular carcinoma: a randomized trial.
Hasegawa K; Takayama T; Ijichi M; Matsuyama Y; Imamura H; Sano K; Sugawara Y; Kokudo N; Makuuchi M
Hepatology; 2006 Oct; 44(4):891-5. PubMed ID: 17006925
[TBL] [Abstract][Full Text] [Related]
17. Hepatocellular carcinoma: the search for innovative adjuvant therapies.
Yen Y; Zhou W
Oncology (Williston Park); 2009 Dec; 23(14):1291, 1294. PubMed ID: 20120843
[No Abstract] [Full Text] [Related]
18. The impact of Milan criteria on liver transplantation for hepatocellular carcinoma: first 15 years' experience of the Hungarian Liver Transplant Program.
Nemes B; Gelley F; Piros L; Zádori G; Görög D; Fehérvári I; Kóbori L; Sárváry E; Nagy P; Kiss A; Doros A
Transplant Proc; 2011 May; 43(4):1272-4. PubMed ID: 21620108
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant therapy with capecitabine postpones recurrence of hepatocellular carcinoma after curative resection: a randomized controlled trial.
Xia Y; Qiu Y; Li J; Shi L; Wang K; Xi T; Shen F; Yan Z; Wu M
Ann Surg Oncol; 2010 Dec; 17(12):3137-44. PubMed ID: 20602260
[TBL] [Abstract][Full Text] [Related]
20. Surgery and transplantation for hepatocellular cancer.
Wall WJ; Marotta PJ
Liver Transpl; 2000 Nov; 6(6 Suppl 2):S16-22. PubMed ID: 11084080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]